Prescribing patterns and factors associated with sodium–glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease
暂无分享,去创建一个
T. Stukel | G. Booth | C. Atzema | J. Udell | K. Tu | A. Chong | Jiming Fang | C. Jackevicius | D. Ko | P. Austin | Aya F. Ozaki | David Naimark | D. Naimark